Advanced imaging technique for measuring cancer metabolism in the body
Official title: Total-body PET Parametric Imaging using Relative Patlak Plot
Funded at University of California at Davis · NIH-11119879 · Data updated 2026-11-12
This study is looking at how a special type of PET scan using a tracer called FDG can give doctors a clearer picture of how cancer is affecting the body, helping them make better decisions about treatment for patients with cancer.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project start | March 1, 2025 |
| Project end | February 28, 2027 |
| Funding year | 2025 |
| Award (this year) | $80,500 |
| NIH project number | 1R03EB037136-01 |
| Project ID | NIH-11119879 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include children and adults undergoing evaluation for cancer diagnosis or treatment.
✕Less likely to help
Patients with non-cancerous conditions or those not requiring metabolic imaging may not benefit from this research.
What this research studies
This research focuses on enhancing positron emission tomography (PET) imaging using a specific tracer, 18F-fluorodeoxyglucose (FDG), to provide detailed insights into metabolic activities associated with cancer. By employing a method called parametric imaging, the study aims to improve the accuracy of cancer diagnosis and treatment assessment compared to traditional imaging techniques. The researchers will utilize advanced total-body PET scanners to capture comprehensive metabolic data across multiple organs, which could lead to better clinical decision-making for cancer therapies.
Why it matters
Potential benefit: If successful, this research could lead to more accurate cancer diagnoses and improved treatment monitoring for patients.
How similar studies have gone: Previous research has shown promising results with similar imaging techniques, indicating potential for significant advancements in cancer diagnostics.
Where this research is happening
-
University of California at Davis
Davis, United States Active
Researchers
- Principal investigator: Li, Siqi — University of California at Davis
- Study coordinator: Li, Siqi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.